We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.50 | 0.78% | 1,352.00 | 1,351.50 | 1,352.50 | 1,352.00 | 1,341.00 | 1,341.00 | 959,571 | 09:59:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.33 | 55.61B |
Date | Subject | Author | Discuss |
---|---|---|---|
13/11/2021 08:42 | £1 = USD 1.34 is good for GSK | tradermichael | |
12/11/2021 18:07 | Thanks for the link. So it would seem the relentless barrage of derision directed at our CEO from many posters here may prove to be a tad premature. Imitation is after all the sincerest form of flattery. | pcok | |
12/11/2021 14:36 | Financial Times@FinancialTimes · 5m Johnson & Johnson is to spin off its consumer products division, best known for Band-Aid plasters and baby shampoo, as the world’s largest healthcare company seeks to focus on pharmaceuticals and medical devices AFP News Agency @AFP · 2h #BREAKING US pharmaceutical giant Johnson & Johnson announces plan to split into two companies | philanderer | |
12/11/2021 14:35 | News out on sotrovimab trial having met its primary endpoint | s2lowner1 | |
12/11/2021 14:02 | Going against the market but just about at £16. I wonder if this would have happened without Elliott. AZN have taken a 4% hit today. | jonjoneil | |
12/11/2021 13:42 | target 1700 in next month or so alw | arja | |
12/11/2021 13:41 | lovely looking chart and mini break out suggests it will | arja | |
12/11/2021 12:56 | GlaxoSmithKline PLC and Vir Biotechnology Inc. said Friday that their Covid-19 treatment sotrovimab has shown positive results for its intramuscular administration. The British pharma major said intramuscular administration of sotrovimab was non-inferior and offered similar efficacy to intravenous administration for high-risk populations. The FTSE 100 listed company said the treatment is aimed at patients with mild-to-moderate Covid-19 in high-risk, non-hospitalized adults and adolescents. Both companies plan to progress regulatory submissions globally, including continuing discussions with the FDA regarding the existing Emergency Use Authorization for sotrovimab, they added. | tradermichael | |
12/11/2021 10:47 | That won't happen - the Club will support her till the bitter end. It will have to come from outside the board and Singer is the Agent of Doom for her. | tradermichael | |
12/11/2021 10:26 | Dame Emma get the bum's rush yet? | purplepelmets | |
12/11/2021 09:27 | With a p/e of 43, its about time AZN took a downturn after appalling results: AZN, 9,123.25 GBX −320.75 (3.40%) today | tradermichael | |
12/11/2021 09:25 | UNLUCKY ....... AZN posted a net loss of $1.65bn (£1.23bn) compared with a profit after tax of around $650m (£486m) in the third quarter last year, a statement said. | tradermichael | |
11/11/2021 17:30 | Back into AZN today looking for a GSK style rise on Q3 results (tomorrow). | bountyhunter | |
11/11/2021 08:35 | I cannot see the price dropping for long next Thursday (ex. div day), given the current performance of the GSK share. | tradermichael | |
10/11/2021 21:22 | The last day you will get entitled to any divi is when the shares start trading as ex-dividend on the London stock exchange and you keep your shares until the following day,shares will drop in value almost by the equal or more amount so there are no guaranteed figures,read the small print to get wiser ! | abdullla | |
10/11/2021 20:32 | If you're planning to sell on ex dividend you will probably find the share price has reduced by the same as the dividend so it will cancel it out | bull19 | |
10/11/2021 20:31 | Ex dividend is 18th November. 14th would be Sunday! | bull19 | |
10/11/2021 18:55 | Ok thanks will hold fire until then | alibizzle | |
10/11/2021 18:26 | Ask Prince Harry. Hes a mystic. Lol. | dosser50 | |
10/11/2021 18:23 | ex-div on 14th Nov. Nobody can answer your second question. | jonjoneil | |
10/11/2021 18:07 | If I sell now will I lose my dividend payments this time round or is it locked in ? Bought at £15.50 a year ago is it worth waiting until it gets to £17 or is that unlikely | alibizzle | |
10/11/2021 11:52 | Because Bill Gates invited her. | pcok | |
10/11/2021 10:22 | It is a nice life for some TM, especially for those with golden tickets (remuneration committee members). Still, I am sure they are all worth every penny for their notable efforts and outstanding achievements... :) Meanwhile, back on GSK matters, looking good for 16 quid before ex div I think. Keep pumping the QE and leave interest rates alone, and the stock markets will continue to run hot for a little while longer IMO. Terrible in the longer term of course, but what will be, will be. | lovewinshatelosses | |
10/11/2021 09:38 | 16 quid this week? | spoole5 | |
10/11/2021 08:08 | grahamburn - so what the hell is she doing on the board of Microsoft (Compensation Committee)? | tradermichael |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions